Navigation Links
Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
Date:5/1/2008

assuming dilution $0.16 $0.09

In-Process Research and Development per common

share assuming dilution $0.00 $0.33

Baxter PI Settlement per common share assuming

dilution $0.00 ($0.15)

Resolution of Tax Contingencies per common share

assuming dilution $0.00 ($0.14)

Non-GAAP Net Income per common share

assuming dilution $2.10 $1.90

CONTACT:

Julie Fallon

Tel. (781) 356-9517

Alternate Tel. (617) 320-2401

fallon@haemonetics.com


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. Haemonetics Appoints Executive Leadership of European Operations
4. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
5. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
6. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
7. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 1The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 2The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 3SCOLR Pharma Inc Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 6607 1SCOLR Pharma Inc Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 6607 2SCOLR Pharma Inc Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 6607 3SCOLR Pharma Inc Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 6607 4Coverage of inexpensive drugs may increase length and quality of life after heart attack 62268 1Coverage of inexpensive drugs may increase length and quality of life after heart attack 62268 2